BFRIW vs TMO
Biofrontera Inc. Warrants (BFRIW) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Biofrontera Inc. Warrants (BFRIW) is a drug manufacturers - specialty & generic company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
BFRIW does not have a complete income-statement cache yet.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
BFRIW currently screens at market cap $0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the BFRIW and TMO stock pages for the full models.
Not investment advice.